title: Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists.
authors.affiliation: Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA. hipskind_philip_a@lilly.com
authors.forename: P A
authors.initials: PA
authors.lastname: Hipskind
authors.forename: K L
authors.initials: KL
authors.lastname: Lobb
authors.forename: J A
authors.initials: JA
authors.lastname: Nixon
authors.forename: T C
authors.initials: TC
authors.lastname: Britton
authors.forename: R F
authors.initials: RF
authors.lastname: Bruns
authors.forename: J
authors.initials: J
authors.lastname: Catlow
authors.forename: D K
authors.initials: DK
authors.lastname: Dieckman-McGinty
authors.forename: S L
authors.initials: SL
authors.lastname: Gackenheimer
authors.forename: B D
authors.initials: BD
authors.lastname: Gitter
authors.forename: S
authors.initials: S
authors.lastname: Iyengar
authors.forename: D A
authors.initials: DA
authors.lastname: Schober
authors.forename: R M
authors.initials: RM
authors.lastname: Simmons
authors.forename: S
authors.initials: S
authors.lastname: Swanson
authors.forename: H
authors.initials: H
authors.lastname: Zarrinmayeh
authors.forename: D M
authors.initials: DM
authors.lastname: Zimmerman
authors.forename: D R
authors.initials: DR
authors.lastname: Gehlert
mesh_terms: D000818:Animals; D004305:Dose-Response Relationship, Drug; D004435:Eating / Q000187:drug effects; D006801:Humans; D007211:Indoles / Q000138:chemical synthesis* / Q000494:pharmacology*; D051379:Mice; D011869:Radioligand Assay; D017476:Receptors, Neuropeptide Y / Q000037:antagonists & inhibitors* / Q000145:classification / Q000378:metabolism; D013329:Structure-Activity Relationship
chemical_list: D007211:Indoles; D017476:Receptors, Neuropeptide Y; C097212:neuropeptide Y-Y1 receptor